HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The Gene Polymorphism of Angiotensin-Converting Enzyme Intron Deletion and Angiotensin-Converting Enzyme G2350A in Patients With Left Ventricular Hypertrophy: A Meta-analysis.

AbstractOBJECTIVES:
The aim of the study was to evaluate the correlation between left ventricular hypertrophy and the gene polymorphism of angiotensin-converting enzyme (ACE) intron deletion (I/D) and ACE G2350A.
METHODS:
Information related to the sample size and genotype frequencies was extracted from each study.
RESULTS:
Our results found that the D allele (p = 0.0180) and DD genotype (p = 0.0110) of ACE I/D had a significant association with increasing the risk of left ventricular hypertrophy, whereas the I allele (p = 0.0180), but not II (p = 0.1660) and ID genotypes (p = 0.1430), was associated with decreasing the risk of left ventricular hypertrophy. On other hand, we found that the A allele (p = 0.0020) and GA genotype of ACE G2350A (p = 0.0070) had the correlation with increasing the risk of left ventricular hypertrophy.
CONCLUSIONS:
Our meta-analysis reveals that the D allele of ACE I/D and the A allele of ACE G2350A are associated with increasing the risk of left ventricular hypertrophy.
AuthorsJonny Karunia Fajar, Budi Susetio Pikir, Erdo Puncak Sidarta, Putu Nina Berlinda Saka, Rizal Rahmanda Akbar, Teuku Heriansyah
JournalIndian heart journal (Indian Heart J) 2019 May - Jun Vol. 71 Issue 3 Pg. 199-206 ISSN: 2213-3763 [Electronic] India
PMID31543192 (Publication Type: Journal Article, Meta-Analysis, Systematic Review)
CopyrightCopyright © 2019 Cardiological Society of India. Published by Elsevier B.V. All rights reserved.
Chemical References
  • Peptidyl-Dipeptidase A
Topics
  • Humans
  • Hypertrophy, Left Ventricular (genetics)
  • Introns
  • Peptidyl-Dipeptidase A (genetics)
  • Polymorphism, Genetic
  • Sequence Deletion

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: